Brovicton

Brovicton may be available in the countries listed below.

Ingredient matches for Brovicton

Itraconazole

Itraconazole is reported as an ingredient of Brovicton in the following countries:

• Greece

International Drug Name Search

Hustless

Hustless may be available in the countries listed below.

Ingredient matches for Hustless

Ambroxol

Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Hustless in the following countries:

• Japan

International Drug Name Search

Mifegest

Mifegest may be available in the countries listed below.

Ingredient matches for Mifegest

Mifepristone

Mifepristone is reported as an ingredient of Mifegest in the following countries:

• India

International Drug Name Search

Cétirizine Ranbaxy Médication Officinale

Cétirizine Ranbaxy Médication Officinale may be available in the countries listed below.

Ingredient matches for Cétirizine Ranbaxy Médication Officinale

Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cétirizine Ranbaxy Médication Officinale in the following countries:

• France

International Drug Name Search

DuraProxin ES Patch

Pronunciation: KAM-for/METH-il sa-LIS-i-late/MEN-thol
Generic Name: Camphor
Brand Name: DuraProxin ES

DuraProxin ES Patch is used for:

Temporary relief of minor muscle and joint aches and pains caused by arthritis, simple backache, strains, sprains, and bruises. It may also be used for other conditions as determined by your doctor.

DuraProxin ES Patch is a topical analgesic. It works by temporarily relieving minor pain.

Do NOT use DuraProxin ES Patch if:

• you are allergic to any ingredient in DuraProxin ES Patch, including oil of wintergreen

Contact your doctor or health care provider right away if any of these apply to you.

Before using DuraProxin ES Patch:

Some medical conditions may interact with DuraProxin ES Patch. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have had an allergic reaction to aspirin or other salicylates


• if you have a wound at the affected area or your skin is broken, reddened, or damaged in any way

Some MEDICINES MAY INTERACT with DuraProxin ES Patch. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Anticoagulants (eg, warfarin) because the risk of their side effects may be increased by DuraProxin ES Patch

This may not be a complete list of all interactions that may occur. Ask your health care provider if DuraProxin ES Patch may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use DuraProxin ES Patch:

Use DuraProxin ES Patch as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• DuraProxin ES Patch is only to be used on intact, clean, dry skin. Do not apply DuraProxin ES Patch to wounds or damaged skin.


• Open pouch and remove patch. If needed, cut patch to size. Peel off protective backing and apply the sticky side to the affected area.


• Wash your hands immediately after using DuraProxin ES Patch.


• Do not bandage tightly after applying DuraProxin ES Patch.


• Do not use DuraProxin ES Patch more often than 3 to 4 times per day.


• If you miss a dose of DuraProxin ES Patch and you are using it regularly, use it as soon as possible. If several hours have passed or if it is nearing time for the next dose, do not double the dose to catch up, unless advised by your health care provider. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use DuraProxin ES Patch.

Important safety information:

• DuraProxin ES Patch is for external use only. Avoid contact with your eyes, ears, lips, mouth, or genital area. If you get it in any of these areas, rinse right away with cool water.


• Do not use a heating pad after you apply DuraProxin ES Patch.


• Do NOT use more than the recommended dose or use more often than directed without checking with your doctor.


• If your symptoms do not get better within 7 days, if they get worse, or if they get better and then return, check with your doctor.


• DuraProxin ES Patch has a salicylate in it. Salicylates have been linked to a serious illness called Reye syndrome. Do not give DuraProxin ES Patch to a child or teenager who has the flu, chickenpox, or a viral infection. Contact your doctor with any questions or concerns


• DuraProxin ES Patch may cause harm if it is swallowed. If you may have taken it by mouth, contact your poison control center or emergency room right away.


• DuraProxin ES Patch should not be used in CHILDREN younger than 12 years old without first checking with the child's doctor; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using DuraProxin ES Patch while you are pregnant. It is not known if DuraProxin ES Patch is found in breast milk after topical use. If you are or will be breast-feeding while you use DuraProxin ES Patch, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of DuraProxin ES Patch:

All medicines may cause side effects, but many people have no, or minor, side effects. No COMMON side effects have been reported with DuraProxin ES Patch. Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); skin redness or irritation.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of DuraProxin ES Patch:

Store DuraProxin ES Patch at room temperature, between 59 and 68 degrees F (15 and 20 degrees C). Store away from heat and light. Do not store in the bathroom. Keep DuraProxin ES Patch out of the reach of children and away from pets.

General information:

• If you have any questions about DuraProxin ES Patch, please talk with your doctor, pharmacist, or other health care provider.


• DuraProxin ES Patch is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about DuraProxin ES Patch. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

Atropin Chauvin

Atropin Chauvin may be available in the countries listed below.

Ingredient matches for Atropin Chauvin

Atropine

Atropine sulfate (a derivative of Atropine) is reported as an ingredient of Atropin Chauvin in the following countries:

• Sweden

International Drug Name Search

Estriel

Estriel may be available in the countries listed below.

Ingredient matches for Estriel

Estriol

Estriol tripropionate (a derivative of Estriol) is reported as an ingredient of Estriel in the following countries:

• Japan

International Drug Name Search

Humex

Humex may be available in the countries listed below.

Ingredient matches for Humex

Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Humex in the following countries:

• Czech Republic


• Luxembourg


• Romania

Ethylmorphine

Ethylmorphine hydrochloride (a derivative of Ethylmorphine) is reported as an ingredient of Humex in the following countries:

• Cyprus

International Drug Name Search

Femme free

Femme free may be available in the countries listed below.

Ingredient matches for Femme free

Naproxen

Naproxen is reported as an ingredient of Femme free in the following countries:

• Australia

International Drug Name Search

Prifinio bromuro

Prifinio bromuro may be available in the countries listed below.

Ingredient matches for Prifinio bromuro

Prifinium Bromide

Prifinio bromuro (DCIT) is also known as Prifinium Bromide (Rec.INN)

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Drisofal

Drisofal may be available in the countries listed below.

Ingredient matches for Drisofal

Gemfibrozil

Gemfibrozil is reported as an ingredient of Drisofal in the following countries:

• Greece

International Drug Name Search